Champions Oncology (CSBR) Revenue (2010 - 2026)

Champions Oncology has reported Revenue for 17 years, with the latest figure at $13.8 million in Q2 2026.

• On a quarterly basis, Revenue rose 11.98% year-over-year to $13.8 million in Q2 2026; TTM through Apr 2026 was $59.4 million, a 4.36% increase from a year earlier, with the FY2026 full-year figure at $59.4 million, up 4.36% from the prior year.
• Revenue was $13.8 million for Q2 2026 at Champions Oncology, down from $16.6 million in the prior quarter.
• The five-year high for Revenue was $17.0 million in Q1 2025, with the low at $11.6 million in Q4 2023.
• Average Revenue over 5 years is $13.7 million, with a median of $13.6 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Revenue declined 18.96% in 2023, then surged 41.77% in 2025.
• Over 5 years, Revenue stood at $14.3 million in 2022, then slipped by 18.96% to $11.6 million in 2023, then increased by 16.56% to $13.5 million in 2024, then rose by 11.46% to $15.0 million in 2025, then retreated by 7.98% to $13.8 million in 2026.
• The last three Revenue figures came in at $13.8 million (Q2 2026), $16.6 million (Q1 2026), and $15.0 million (Q4 2025), per Business Quant data.